Nemaura Medical Stock Beta
Nemaura Medical fundamentals help investors to digest information that contributes to Nemaura Medical's financial success or failures. It also enables traders to predict the movement of Nemaura Pink Sheet. The fundamental analysis module provides a way to measure Nemaura Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nemaura Medical pink sheet.
Nemaura |
Nemaura Medical Company Beta Analysis
Nemaura Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Nemaura Medical Beta | 0.046 |
Most of Nemaura Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nemaura Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Nemaura Medical has a Beta of 0.046. This is 94.65% lower than that of the Health Care Equipment & Supplies sector and 95.58% lower than that of the Health Care industry. The beta for all United States stocks is 130.67% lower than that of the firm.
Nemaura Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nemaura Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nemaura Medical could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics of similar companies.Nemaura Medical is currently under evaluation in beta category among its peers.
As returns on the market increase, Nemaura Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nemaura Medical is expected to be smaller as well.
Nemaura Fundamentals
| Return On Equity | -7.24 | ||||
| Return On Asset | -0.49 | ||||
| Current Valuation | 22.58 M | ||||
| Shares Outstanding | 28.9 M | ||||
| Shares Owned By Insiders | 48.30 % | ||||
| Shares Owned By Institutions | 7.70 % | ||||
| Number Of Shares Shorted | 52.57 K | ||||
| Price To Earning | (707.14) X | ||||
| Price To Book | 122.56 X | ||||
| Price To Sales | 804.62 X | ||||
| Revenue | 77.04 K | ||||
| Gross Profit | (1.48 M) | ||||
| EBITDA | (8.17 M) | ||||
| Net Income | (14.14 M) | ||||
| Cash And Equivalents | 14.75 M | ||||
| Cash Per Share | 0.61 X | ||||
| Total Debt | 20.03 M | ||||
| Current Ratio | 0.99 X | ||||
| Book Value Per Share | (0.55) X | ||||
| Cash Flow From Operations | (8.45 M) | ||||
| Short Ratio | 0.30 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 36 | ||||
| Beta | 0.046 | ||||
| Market Capitalization | 2.43 M | ||||
| Total Asset | 14.56 M | ||||
| Retained Earnings | (51.88 M) | ||||
| Working Capital | (8.73 M) | ||||
| Current Asset | 9.55 M | ||||
| Current Liabilities | 658.01 K | ||||
| Z Score | -7.48 | ||||
| Net Asset | 14.56 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |